ModivCare Inc. (MODVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0050 (50.00%)
At close: Dec 29, 2025
← View all transcripts

2024 Leerink Partners Healthcare Crossroads Conference

May 30, 2024

John French
VP of Institutional Equity Sales, Leerink

John French from one of the healthcare services and managed care analysts here at Leerink. I have with me Barbara Gutierrez, CFO of Modivcare, and up front, I have Kevin Ellich, Head of Investor Relations at Modivcare. Thank you guys for being here.

Barbara Gutierrez
CFO, Modivcare

Yeah, thanks for having us.

John French
VP of Institutional Equity Sales, Leerink

I guess to start, can you talk a little bit about your background and how you came into your current position?

Barbara Gutierrez
CFO, Modivcare

Yeah, absolutely. So I have a really deep healthcare background. Been in some different industries, but really have a deep healthcare background. And most recently, I was the Chief Financial Officer of a company called InnovAge, which is a Program of All-Inclusive Care for the Elderly.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

And PACE programs, you know, deal with all the medical needs of the participants, but the social determinants of health as well. So, this opportunity presented itself to me, and Modivcare, just a natural fit-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... with the social focus on the social determinants of health. And personally just have a passion for healthcare, particularly with vulnerable populations.

John French
VP of Institutional Equity Sales, Leerink

Great. I guess for the new investors or those unfamiliar with your organization, can you touch on the story of Modivcare and kind of the long-term vision of the company?

Barbara Gutierrez
CFO, Modivcare

Yeah, absolutely. So Modivcare itself is a tech-enabled healthcare services company focused on supportive care services around the social determinants of health. And while we are a very integrated company and really speak about being one Modivcare, we operate in three business segments, primarily: non-emergency medical transportation, NEMT, personal care services, and remote patient monitoring. So the overall vision is really improving health outcomes and participant and member experience by really the connections to care. So really providing the access and the connections to care for these particularly vulnerable populations.

John French
VP of Institutional Equity Sales, Leerink

Great. And then, I guess, can you touch on the interplay between those three different kind of unique and distinct assets? You know, some of the synergies between them and how they create a differentiated platform around the social determinants of health.

Barbara Gutierrez
CFO, Modivcare

Yeah, of course. Again, really, we approach it from a Modivcare standpoint, really, this integrated approach, and really try to approach it even with our clients, about how we can offer more to these, to folks who typically may not have access to care. So really, what we do with all of our business segments is help close those gaps of care and produce better outcomes, which ultimately also reduces the overall cost of care. So we've done things like pilots with a very large payer in the Midwest, where we've combined both the NEMT benefits and the remote patient monitoring benefits with great success.

And one of the things that has come out of that is, we did a survey of these members and asked them things like, you know, "What are the barriers to care for you?" And a number of them, somewhere between, you know, upwards of 30%, said: "Transportation is a barrier to care," when in fact, these folks actually have a benefit, transportation benefit and don't even realize it. So for us, it's about that member engagement and connections to care. We really have the access to members and that connection to care.

John French
VP of Institutional Equity Sales, Leerink

Gotcha. And so I know you take risk on some of these, on your transportation business. Can you talk about how utilization has trended these past few months and how the overall demand environment for your services has trended recently?

Barbara Gutierrez
CFO, Modivcare

Yeah. So I'll speak about them, the segments a little bit differently.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

For PCS, really, it's pretty much a, you know, a fee-for-service type-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... type business. Our PCS business has grown at market rates in the low single digits. So there's just a constant demand for that. I haven't really seen any unusual change in utilization. Remote Patient Monitoring is on a subscription kind of basis. So when we talk about utilization, it's primarily around our NEMT business.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

And so obviously, you know, during the pandemic, things were very different, low utilization. Coming out of the pandemic, I think all healthcare, all healthcare services, we certainly know the payers have reported, higher utilization as things return to a little bit normal levels. So, currently, around 10% utilization in that business. We think the normal level will be around 11% of our-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... population utilizing the service. When we look back at the history, we had higher levels of utilization pre-COVID, but really that was during a time, I think, of less managed care.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

And so we don't believe we'll return to those levels of net 13%, but somewhere in that 10%-11% is really what we anticipate the normal level of utilization.

John French
VP of Institutional Equity Sales, Leerink

Got you. Great, that's very helpful. I guess another macro headwind that's kind of been going on is around redeterminations-

Barbara Gutierrez
CFO, Modivcare

Mm-hmm

John French
VP of Institutional Equity Sales, Leerink

... so I was wondering if you can give us an updated view on how redeterminations have tracked versus your expectations?

Barbara Gutierrez
CFO, Modivcare

Yep.

John French
VP of Institutional Equity Sales, Leerink

Is the $26 million-$30 million headwind in 2024 still the right number?

Barbara Gutierrez
CFO, Modivcare

Yes. So, so yes and yes. So really, redetermination has tracked according to our expectations, maybe even on the slightly lower end of the range. So we're really happy now that we are in our top states, where we have full risk contracts. We're more than 80%-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... through redetermination, so really at the peak levels of getting through that process. So it's really good to have that transparency and that visibility for redetermination. And so, yeah, that's the right number. We think over the course of the redetermination period, we'll lose about a little over 3 million of our Medicaid members, somewhere in the neighborhood of 10%-15% of those folks. So really, really tracking in line with our expectations. Certainly, a big headwind, but the good news is tracking in line with our expectations, and we'll be peaking and tapering off going forward.

John French
VP of Institutional Equity Sales, Leerink

Yeah, I know this is kind of an impossible question, but any early indications on how re-enrollment for individuals procedurally disenrolled is tracking?

Barbara Gutierrez
CFO, Modivcare

... early, early.

John French
VP of Institutional Equity Sales, Leerink

Yeah.

Barbara Gutierrez
CFO, Modivcare

Yeah, I think a number of folks have said, you know, somewhere between 23%-30% of those people will come back, and we believe that's in line with our expectations.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

Could be a tailwind for us, but it's a little bit early to tell, but we do think a number of those folks will come back.

John French
VP of Institutional Equity Sales, Leerink

Gotcha. Thank you. And then related to this topic, state Medicaid populations have changed quite a bit recently, given redeterminations. Can you give us some insight on how your discussion around rates-

Barbara Gutierrez
CFO, Modivcare

Mm-hmm

John French
VP of Institutional Equity Sales, Leerink

... with states and your MCO partners have been going recently, given these changing pools?

Barbara Gutierrez
CFO, Modivcare

Yeah, I would say the word I would use to characterize these discussions is it's stable. It's a stable environment. You know, certainly, there are some reimbursement headwinds in both Medicaid and Medicare-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... but I think a stable environment. Transportation is a codified benefit under Medicaid, and so it's a necessity. And so I think our rate discussions have been and really stable and very positive going forward. And you know, we have a diversity of contract types. We, the majority of our contracts are in the shared risk-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... category, which is really a win-win for both us and the payers, really flexing on both utilization and cost.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm. I know this is a smaller portion of your business, but, Medicare Advantage has been facing a number of different reimbursement headwinds.

Barbara Gutierrez
CFO, Modivcare

Mm-hmm.

John French
VP of Institutional Equity Sales, Leerink

And a lot of different carriers have kind of signaled to the market that they might be pulling back on benefits, particularly around social determinants of health and some supplemental benefits. How does that impact Modivcare and...?

Barbara Gutierrez
CFO, Modivcare

Yeah. So first of all, in terms of the overall business, Medicare is about 16%, right?

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

So it's a, it's a smaller end of our business. You know, I was speaking with some folks this morning and last night, and I think while those supplemental benefits, you know, for a number of years, I will say, were a little bit of the bells and whistles-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... and were used as a tool to recruit new enrollees. But the reality is, the people that utilize the benefit need the benefit, and I think while it may not grow necessarily as fast as it has grown over the past several years, my opinion is I don't think it's gonna go away because it's a necessary benefit. So, we're cognizant of that and continuing to have just real open dialogue with our MCO partners.

John French
VP of Institutional Equity Sales, Leerink

That's great. Can you provide us an update regarding your RFP pipeline? I believe there are several state contracts that are up for renewal this year.

Barbara Gutierrez
CFO, Modivcare

Yes. So 2024 is, what we call an outsized year for renewals. There's just a number of the contracts, up for renewal this year, mostly in the latter half of the year. So in some of our investor, disclosures, you know, we've got nearly $600 million of renewals, this year. There's, one large state renewal in there, one of our larger payers. All going well. Some of it may get pushed to 2025-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... because we actually haven't gotten any indications that there's gonna be anything going up for RFP yet, and a number of those contracts actually have some extension clauses. So we believe a number of those will just be extended.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

We've got a really good history track record of retaining those, that business.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

Some of that business we've had for more than 10 years.

John French
VP of Institutional Equity Sales, Leerink

Any early thoughts on how the pipeline looks into 2025 and beyond?

Barbara Gutierrez
CFO, Modivcare

Yeah, I think, I think the pipeline will be around MCOs in 2025. And again, because a lot of the state business is already renewing here in 2024. And so I think, I think unless some of it gets extended, the pipeline will be focused around 2025.

John French
VP of Institutional Equity Sales, Leerink

Great. Can you give us an update around your cost-saving initiatives in your transportation business and how they're trending versus expectation?

Barbara Gutierrez
CFO, Modivcare

Yeah. Again, trending according to our expectations, you know, the company is going through a transformation that started in 2023. So we embarked on a number of cost savings initiatives in 2023, and some additional ones in 2024, primarily in three areas. So around what we call omni-channel member engagement. So, really, uplifting our technology so that members have more seamless and automated ways of connecting with us.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

Things through IVR and text and an app. So really modernizing the technology, so that's going along well. You know, the more we do of that, obviously, there'll be less humans and other things that are costs, that have a cost impact, so that's part of our cost savings. Also focusing on a multimodal network. So what's the right type of ride for our members?

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

And so some may be ride share, some may be, you know, family reimbursement, it might be public transportation. So really focusing on what's the right type, and those types of transportation have different cost profiles. So that's one, then the second one, and then the third one is just around the digital customer experience. So things like we just announced our Integration Hub-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... where we're exposing some APIs and really connecting with, with payers and health systems to make it easier, and seamless for the members. So all of those things, really in the realm of, you know, $30 million-$50 million of cost savings, with an exit of potentially $60 million.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

So, really modernizing and streamlining our operations.

John French
VP of Institutional Equity Sales, Leerink

Yeah, I think you gave some numbers at the end. Do you still expect roughly $34 million of those?

Barbara Gutierrez
CFO, Modivcare

Yes

John French
VP of Institutional Equity Sales, Leerink

... $60 million savings in 2024?

Barbara Gutierrez
CFO, Modivcare

Yes.

John French
VP of Institutional Equity Sales, Leerink

Any update on the quarterly timing of those savings?

Barbara Gutierrez
CFO, Modivcare

Yeah. So we recognized some of those savings in 2023, so some will carry over. But really in Q2, Q3, and Q4-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... new initiatives and then the momentum from some of the implementation. So, you know, a little bit more back half weighted.

John French
VP of Institutional Equity Sales, Leerink

... Gotcha. And then you, you touched on a little bit of some of the investments you're making on your digital transformation and some of your new APIs.

Barbara Gutierrez
CFO, Modivcare

Mm-hmm.

John French
VP of Institutional Equity Sales, Leerink

I'm wondering if we could double-click on that a little bit.

Barbara Gutierrez
CFO, Modivcare

Yeah. So really, all of those, all of those things related to the digital transformation. So we launched an app. We implemented a cloud-based member care software-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

late last year, that, you know, AI-related software.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

So, you know, it's really anything that's just digitizing and automating, you know, things that we were a little bit behind in some of our technology, so a big effort, focus, and investment in technology. Didn't ask, but I'll also expand on PCS-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

is another area where we're investing.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

So our home care business was a roll-up of roll-ups. Very decentralized. There was. We had upwards of 5-7 caregiving systems, you know, not on the same payroll systems, not on the same ERP. So another investment that we've made over the last year is streamlining operations, consolidating some of those functions, and really getting onto single platforms. So another big investment we've made.

John French
VP of Institutional Equity Sales, Leerink

Okay, great. And then I guess, can you discuss some of your ongoing initiatives inside of your non-emergency medical transportation segment to capture additional revenue from your current pipeline and how that's kind of manifested in 2024?

Barbara Gutierrez
CFO, Modivcare

Yeah. So really, it is about this. It's about the integration and the one Modivcare type services. So, you know, I think it's pretty easy to understand the segments individually. They have value individually, but they also have value in an integrated way. So one is. I mentioned the pilot we did with-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

a large payer to, you know, how can we combine remote patient monitoring with PCS? Or, you know, because we have access to the members, how can we get them to utilize their benefits? So it's really about this one Modivcare strategy.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm. And then back on the PCS business a little bit. Can you give, give us an update on how labor rates, recruiting, retention is tracked?

Barbara Gutierrez
CFO, Modivcare

Yeah. You know, we've been very focused and very pleased with our recruiting and retention.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

95% monthly retention of our caregivers. We have a very large caregiver workforce, about 17,000 caregivers. And so, very pleased about the recruiting and the retention. Labor rates, while we've seen a little bit of a spike in Q1 that we talked about in certain areas, we think it's really leveling off. And for us, it's really about keeping our rates in sync with the increases in minimum wage and those type of rates. And in Q1, we talked about we had a little bit of a mismatch in. We had some increases in one state where the minimum wage went up, but we didn't get corresponding rate increases till the first of March.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

In Q1, a little bit of a mismatch, but going forward, we expect that to be pretty in line.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm. And then I was wondering if you could touch on, maybe there's a number of incumbents that have kind of entered into the personal care space through Uber.

Barbara Gutierrez
CFO, Modivcare

Mm-hmm

John French
VP of Institutional Equity Sales, Leerink

... I think it's Uber Caregiver.

Barbara Gutierrez
CFO, Modivcare

Yep.

John French
VP of Institutional Equity Sales, Leerink

How has that impacted your business? Sometimes I know they can be some of your partners, actually, so.

Barbara Gutierrez
CFO, Modivcare

Yeah, Uber Caregiver really is also around the transportation-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

Really around transportation. So Uber itself, and Lyft, big partners of ours.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

So very big partners. You know, what, what we really see is, there's so many underserved and unserved people in the, in this particular segment of the market.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

3.6 million, I think, 3.6 million folks is in a survey by the American Hospital Association, you know, go without care because they don't have transportation. So, you know, we really applaud Uber and, and others for getting into the space, and they're a big partner of ours. I think there's plenty of people to be served.

John French
VP of Institutional Equity Sales, Leerink

Great. Can you touch on your capital priorities, balance sheet, and plans around refinancing some of your more near-term maturities?

Barbara Gutierrez
CFO, Modivcare

Yes. So, you know, hot, hot topic and top priority are both of those things, and we are right in the process of refinancing our 2025-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

Notes. So we disclosed that at our last earnings. We're in the process and expect that to be completed very shortly. So that's good news. That'll get us that behind us, you know, with the goal of some flexibility.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

Because our second goal is also delevering-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

And really any proceeds or free cash flow, really delevering the balance sheet. So, that's the second priority. Want to have flexibility in that refinancing to be able to do that.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm. Yeah, and so in terms of just capital deployment, it's all right now on deleveraging. I think you said at a 4.7x net leverage ratio?

Barbara Gutierrez
CFO, Modivcare

Yeah, we were at 4.9 at the end of Q1.

John French
VP of Institutional Equity Sales, Leerink

Okay.

Barbara Gutierrez
CFO, Modivcare

So yes, definitely delevering. You know, the business is actually generates on an unlevered basis-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

$100 million-$150 million of free cash flow in this year is our projection.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

Not a highly capital-intensive business, so definitely generates free cash flow, and, you know, we'll get some of this refinancing behind us and be able to focus on delevering.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm. And then kind of on that topic, I guess, a little bit is, can you spend a minute talking about your investment in Matrix Medical and then your plans to monetize this asset?

Barbara Gutierrez
CFO, Modivcare

Yep. So we have a just under 44% stake, a minority stake in Matrix. Matrix is a risk assessment business, quite successful, second largest behind Signify's previous business. And so it is our intent to monetize that asset. We have a good relationship with our partner, Frazier, and intend to monetize that business. Our current target is the end of this year or early 2025. You know, we think that'll bring us some significant proceeds to help us delever the balance sheet.

John French
VP of Institutional Equity Sales, Leerink

... Great! And then, I guess this is kind of a little bit of a longer-term question, but, what opportunities and maybe even risks does generative AI pose for your business? And does this represent a significant opportunity to streamline logistics in your transportation business?

Barbara Gutierrez
CFO, Modivcare

Yeah, I think it's definitely an opportunity, not so much a risk.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

We kinda joke if Heath was here.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm.

Barbara Gutierrez
CFO, Modivcare

He'd go on for quite a while about AI. We really embraced it, really embraced it as a company, not only internally, but as it relates to the NEMT business. I mentioned we implemented this cloud-based software late last year that really has an AI engine.

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... that helps with really matching the member with the ride and, you know, the most streamlined way of finding the right ride for the member. So as a company, we really embrace it. We think it'll really help continue to streamline and automate our business.

John French
VP of Institutional Equity Sales, Leerink

Gotcha. And then, I guess, touching back on growth, as you guys think about your growth algorithm, and we could, we could start on just the transportation business first, are you looking to enter into new states, new markets when you expand, or are you focused more on just taking your current existing footprint and then kind of expanding, you know, inside different populations in there, or really expanding upon your initial chassis of, your footprint?

Barbara Gutierrez
CFO, Modivcare

Yeah. I think it's, I think it's all of that. I think we are currently in 48 states-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... with the NEMT, so I think it is continuing to, you know, win new markets within the state-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... as well as just really focusing on, you know, new MCO customers, new segments of the business, like you said. So I think we've got a-- we have a very large footprint-

John French
VP of Institutional Equity Sales, Leerink

Mm-hmm

Barbara Gutierrez
CFO, Modivcare

... and we just intend to just capitalize on that in every state.

John French
VP of Institutional Equity Sales, Leerink

Great. I guess we'll just take a second and see if anyone in the audience has any questions. Great. Well, we have a little bit of time left, but I guess I'll let you off a little bit early.

Barbara Gutierrez
CFO, Modivcare

Okay. All right. Thank you very much.

John French
VP of Institutional Equity Sales, Leerink

Great. Thanks, Barbara.

Barbara Gutierrez
CFO, Modivcare

Thanks for the conversation.

Powered by